43 results
Page 2 of 3
8-K
x86djdye8xt
24 Jan 22
Entry into a Material Definitive Agreement
8:00am
424B3
kqeqpr901h2
14 Jan 22
Prospectus supplement
5:18pm
424B5
azm8oefsidol4 1y9
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
xe2k4hgx
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
w0i0zz5xnvr4uswd
22 Nov 21
Definitive proxy
4:37pm
424B5
mijkt4txq9880cnfppwi
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
xxajfa9d
14 May 21
Quarterly report
4:31pm
10-K
9dqp9gka0op6j30zv
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
st2m7s
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
8-K/A
EX-99.1
w54kf rmhwhos0pgxtw1
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.2
mu440lbbbf6
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
fg1wo6kim48a1dyqatqw
2 Nov 20
Prospectus supplement
12:00am